Cite
HARVARD Citation
Giamarellos‐Bourboulis, E. et al. (2020). Clinical efficacy of complement C5a inhibition by IFX‐1 in hidradenitis suppurativa: an open‐label single‐arm trial in patients not eligible for adalimumab. British journal of dermatology. pp. 176-178. [Online].